Regen BioPharma Inc Stock OTC Bulletin Board
Equities
US75886M1027
Biotechnology & Medical Research
Sales 2022 | 236K 322K | Sales 2023 | 237K 324K | Capitalization | 6.33M 8.66M |
---|---|---|---|---|---|
Net income 2022 | 2M 2.74M | Net income 2023 | 1M 1.37M | EV / Sales 2022 | 144 x |
Net Debt 2022 | 1.22M 1.67M | Net Debt 2023 | 635K 869K | EV / Sales 2023 | 29.4 x |
P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.99% |
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
1st Jan change | Capi. | |
---|---|---|
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |